查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197524

医疗电子市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Medical Electronics Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计在预测期内，医疗电子市场的复合年增长率为 10.9%。

COVID-19 最初影响了医疗电子市场。 大流行期间成像量的下降影响了前一阶段的市场增长速度。 例如，2021 年 7 月发表在美国放射学会杂誌上的一篇论文报告称，2020 年（第 1-16 週）的总成像量与上一年相比下降了 12.29%。 他们还报告说，COVID-19 后（第 10-16 週）显示所有患者服务站点的成像量减少幅度更大 (28.10%)。 同一份文件还报告说，在 16 週时，动态成像减少了 88%，其中 MRI 减少了近 74%。 这种由大流行引起的销量下降正在对流行病中的市场增长产生影响。 然而，在大流行期间，患者监测设备的需求显着增加，因为它们使临床医生能够进行非接触式交流并跟踪医疗状况。 此外，X射线成像在COVID-19及相关疾病诊断和治疗中的应用对大流行后期的市场增长产生了积极影响。 例如，2021 年 6 月发表在 BMC 肺医学杂誌上的一篇论文证实了胸部 X 光片可用于 COVID-19 肺炎患者的诊断和随访。 因此，在后疫情阶段，由于放鬆管制、恢復诊疗服务以及医学影像设备的高渗透，对医疗电子的需求增加，有望真正恢復。

这是由于慢性病发病率和患病率上升以及老年人口增加以及诊断成像设备的使用范围扩大等因素造成的。

癌症、神经系统疾病、心血管疾病和呼吸系统疾病等慢性病负担日益加重是推动市场增长的关键因素。 例如，根据 IDF 发布的 2022 年统计数据，全球约有 5.37 亿 20-79 岁的成年人患有糖尿病，这一数字在 2030 年和 2045 年上升到 6.43 亿。预计到 2020 年将增加到 7.83 亿。 因此，越来越多的糖尿病和肥胖患者增加了患其他慢性疾病（如冠状动脉疾病、高血压和中风）的风险，从而增加了对心脏病的早期检测和定期监测的需求。 因此，对心脏病的早期检测和定期监测的需求越来越大，预计这将在预测期内推动市场增长。

此外，根据阿尔茨海默氏症协会 2022 年报告中公布的数据，德国有超过 150 万人患有阿尔茨海默氏症，预计到 2050 年这一数字将翻一番。 这将增加对早期发现和了解与轻度认知障碍相关的大脑异常的神经病理学机制的需求。 预计这将进一步增加对 MRI 和 CET 扫描检查的需求，推动市场增长。

衰老是各种分子和细胞损伤随时间累积，导致身心能力逐渐下降，患病风险增加。 老年人的常见疾病包括背部和颈部疼痛、骨关节炎、慢性阻塞性肺病、心脏病和癌症。 例如，根据澳大利亚统计局2022年3月更新，2020-2021年澳大利亚心脏病患病率为4.0%，相当于约100万人。 统计数据还显示，在澳大利亚，心脏病随着年龄的增长而增加，从 45-54 岁人群的 2.3% 增加到 75 岁及以上人群的 23.2%，其中男性受影响最大。 老年人更容易患心脏病，预计这将增加对诊断医疗电子设备的需求，这有望推动市场增长。

此外，预计在预测期内，增加产品发布和批准也将推动市场增长。 例如，2022 年 3 月，Rapid Response Revival 宣布推出首批使用先进技术的个人门诊除颤器之一，旨在增加心臟骤停的倖存机率。CellAED 在英国上市。

此外，增加政府资金和增加企业开发先进产品的活动也促进了市场增长。 例如，2021 年 7 月，价值 31 亿欧元（32.8 亿美元）的新磁共振成像 (MRI) 扫描仪设施在莱斯特开业。 新设施将使研究人员的成像能力从目前每年 500 名心血管研究参与者增加到 1,500 名。 新的扫描仪设施由 BHF 提供的 100 万欧元（110 万美元）赠款资助。 该设施将由莱斯特医院和莱斯特大学共同拥有，后者出资 210 万欧元（220 万美元）。

因此，由于上述因素，预计所研究的市场在预测期内将会增长。 然而，设备审批的严格规定和设备的高维护成本预计将在预测期内阻碍医疗电子市场的增长。

医疗电子市场趋势

在市场细分方面，预计 MRI 细分市场在预测期内将占据较大的市场份额

由于先进 MRI 系统的引入以及 MRI 系统在新兴国家的渗透率不断提高等因素，预计在预测期内，磁共振成像 (MRI) 领域将见证医疗电子市场的显着增长。 许多新兴国家人口稠密，医疗基础设施发达。 在这些地区，除了老龄化社会的进展之外，由于癌症、肌肉骨骼疾病和神经系统疾病等疾病的负担很大，预计未来 MRI 系统的采用将会增加。

技术先进系统的开发及其采用和产品发布的增加预计将增加这些系统在市场上的可用性，并在预测期内促进细分市场的增长。 例如，2021 年 2 月，Insitec 的 Exablate 4000（Exablate Neuro）平台获得了巴西 HRA ANVISA 的市场批准。 据说该平台使用 MR 引导的聚焦超声在没有切口的情况下精确消融大脑深处的组织，从而能够治疗特发性震颤和以震颤为主的帕金森病。 同样，2021 年 10 月，Esotee 将推出全身磁共振成像系统“Magnifico Open”，这是一种最先进的开放式 MRI 系统，不仅可以满足临床需求，还可以满足运营和财务需求。

此外，专注于采用扩张、协作等各种关键战略的公司的兴起也有助于该细分市场的增长。 例如，2021 年 11 月，位于印度哈里亚纳邦的 NBRC 启用了先进的 MRI 设备。 此外，2021 年 7 月，一个价值 31 亿欧元（32.8 亿美元）的新磁共振成像 (MRI) 扫描仪设施将在莱斯特启用，研究人员的成像能力从目前的每年 500 人增加到 1,500 人。 新的扫描仪设施由 BHF 提供的 100 万欧元（100 万美元）赠款资助。

因此，由于上述因素（例如产品发布数量增加和企业活动增加），预计所研究的细分市场将在预测期内实现增长。

预计在预测期内北美将占据很大的市场份额

北美将在预测期内主导市场，原因包括人口增长导致慢性病负担不断增加、医疗保健系统中先进技术的使用增加、完善的医疗保健基础设施以及高昂的医疗保健成本. 预计。 预计在预测期内，对微创治疗的需求不断增长和医疗电子技术的进步也将推动市场增长。

慢性病患病率和负担的增加是推动该地区医疗电子产品需求的一个关键因素。 例如，根据疾病预防控制中心发布的数据，2022 年 4 月，估计到 2040 年美国将有 3500 万成年人患有关节炎。 因此，对提供关节和周围组织详细图像并有助于早期发现症状的医疗电子设备的需求预计将推动市场增长。 根据ACS公布的2022年统计数据，2022年美国和新墨西哥州预计将分别新增超过190万癌症患者和11030例新癌症患者。 根据加拿大癌症协会发布的2022年统计数据，预计2022年加拿大将诊断出约233,900例新癌症病例。 随着癌症患者数量的增加，对 MRI 和 CT 扫描等有助于早期检测体内肿瘤的医疗电子设备的需求也在增加。 预计这将在预测期内推动市场增长。

此外，企业产品开发活动的增加和产品发布的增加也促进了市场增长。 例如，2022 年 2 月，Esaote 的新型开放式全身 MRI 系统 Magnifico Open MRI 在美国获得 FDA 批准。 同样在 2021 年 7 月，美国食品和药物管理局批准了两种 Acurhythm 人工智能（AI）算法用于美敦力（Medtronic）的 LINQ II 插入式心臟监护仪（ICM）。

因此，由于人口中关节炎和癌症的高负担以及企业活动增加等因素，预计该地区的研究市场将在预测期内增长。

医疗电子市场竞争对手分析

由于存在许多大型企业，医疗电子市场竞争激烈。 从市场份额的角度来看，一些主要参与者目前主导着市场。 一些主要参与者正在积极寻求与其他公司的收购和合资企业，以巩固其在全球的市场地位。 目前主导市场的公司包括 Medtronics PLC、GE Healthcare、Koninklijke Philips NV、Siemens Healthcare GmbH 和 Fujifilm Corporation。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 老年人口增加
    • 增加成像设备的应用
  • 市场製约因素
    • 加强监管机构的监督
    • 高成本和维护
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品分类
    • 非侵入性产品
      • 核磁共振
      • X光
      • CT扫描
      • 超声诊断设备
      • 核医学成像系统
      • 心臟监测仪
      • 呼吸监测仪
      • 血流动力学监测仪
      • 多参数监护仪
      • 数字温度计
      • 其他产品
    • 侵入性产品
      • 内窥镜
      • 起搏器
      • 植入式心律转復除颤器 (ICD)
      • 嵌入式循环记录器
      • 脊髓刺激器
      • 其他侵入性产品
  • 通过申请
    • 诊断设备
    • 监控
    • 治疗设备
  • 最终用户
    • 医院和诊所
    • 门诊手术中心
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Medtronic PLC
    • GE Healthcare
    • Koninklijke Philips NV
    • Siemens Healthcare GmbH
    • Fujifilm Corporation
    • McKesson Corporation
    • Olympus Corporation
    • Hologic Inc.
    • Dragerwerk AG & Co. KGaA
    • Getinge Inc.
    • Esaote SpA
    • Canon Medical Systems
    • Mindray Medical International Limited

第7章 市场机会与今后动向

简介目录
Product Code: 67992

The medical electronics market is expected to witness a CAGR of 10.9% during the forecast period.

COVID-19 impacted the medical electronics market initially. The decrease in imaging volumes during the pandemic affected the growth pace of the market in the preliminary phase. For instance, an article published in the Journal of the American College of Radiology in July 2021, reported that the total imaging volume in 2020 (weeks 1-16) declined by 12.29% as compared to the previous year. It also reported that post-COVID-19 (weeks 10-16) revealed a greater decrease (28.10%) in imaging volumes across all patient service locations. The same source also reported that an 88% decline was seen at week 16 in outpatient imaging, and MRI contributed to a nearly 74% decline. Such a decline in volumes due to the pandemic has impacted market growth amid the outbreak. However, the demand for patient monitoring devices greatly increased during the pandemic period as they allowed contactless communication and tracking of medical conditions by clinicians. Moreover, the application of x-ray imaging for the diagnosis and treatment of COVID-19 and associated diseases has positively impacted the market's growth in the latter phase of the pandemic. For instance, from an article published in BMC Pulmonary Medicine Journal, in June 2021, it has been observed that a chest x-ray was used to diagnose and follow up patients with COVID-19 pneumonia. Thus, with the relaxed restrictions, resumed diagnosis and treatment services, and the high adoption of medical imaging equipment, the demand for medical electronics has increased in the post-pandemic phase, and as per the analysis, the market is expected to regain its full potential in the next two to three years.

The factors such as the rising incidence and prevalence of chronic diseases coupled with the increasing geriatric population and the growing application of imaging devices.

The increasing burden of chronic diseases such as cancer, neurological diseases, cardiovascular diseases, respiratory diseases, and others are the key factor driving the market growth. For instance, according to the 2022 statistics published by the IDF, about 537 million adults aged between 20-79 were living with diabetes globally, and this number is projected to increase to 643 million and 783 million by 2030 and 2045, respectively. Thus, the higher number of diabetic and obese people increases the risk of developing other chronic diseases such as coronary artery disease, hypertension, and stroke, which increases the need for early detection as well as regular monitoring of the heart condition. This is anticipated to fuel market growth over the forecast period.

Additionally, as per data published in the Alzheimer's Association 2022 report, more than 1.5 million people in Germany were suffering from Alzheimer's disease, and this number is expected to double by 2050. This is anticipated to increase the need to early detect the brain abnormalities associated with mild cognitive impairment as well as understand the neuropathological mechanisms. This is further expected to fuel the demand for MRI and CET scan testing, thereby bolstering the market growth.

Aging results from accumulating a wide variety of molecular and cellular damage over time, leading to a gradual decrease in physical and mental capacity and a growing risk of disease. Common conditions in older age include back and neck pain and osteoarthritis, chronic obstructive pulmonary diseases, heart diseases, cancer, and others. For instance, according to the March 2022 update of the Australian Bureau of Statistics, the prevalence of heart disease in Australia was 4.0% in 2020-2021, which equates to about 1 million people. Also, as per the same source, in Australia, heart disease increased with age, from 2.3% of people aged 45-54 years through to 23.2% of people aged 75 years and over, with males being the most affected by it in the country. Since the older population is prone to the disease, it is expected to generate the need for medical electronics for diagnosis, thereby driving the market's growth.

Furthermore, rising product launches and approvals are also expected to increase market growth over the forecast period. For instance, in March 2022, Rapid Response Revival launched CellAED, one of the first personal, portable defibrillators that use sophisticated technology designed to improve the chances of surviving a sudden cardiac arrest, in the United Kingdom.

Moreover, the increasing government funding, as well as rising company activities for developing advanced products, are also contributing to the market growth. For instance, in July 2021, a new magnetic resonance imaging (MRI) scanner facility opened in Leicester, worth EUR 3.1 billion (USD 3.28 billion). This new facility increases the current imaging capacity of researchers from 500 cardiovascular research participants a year to 1,500. The new scanner facility has been funded by a EUR 1 million (USD 1.1 million) grant from the BHF. It will be jointly owned by Leicester's Hospitals, which has dedicated EUR 2.1 million (USD 2.2 million) to the facility, and the University of Leicester.

Therefore, owing to the aforementioned factors, the studied market is expected to grow over the forecast period. However, the strict regulations for device approval and the high cost of maintenance of the devices are expected to hinder the growth of the medical electronics market over the forecast period.

Medical Electronics Market Trends

MRI Segment Expected to Hold Significant Market Share in the Medical Electronics Market Over the Forecast Period

The magnetic resonance imaging (MRI) segment is expected to witness significant growth in the medical electronics market over the forecast period owing to factors such as the introduction of advanced MRI systems and the rising adoption of MRI systems in emerging markets. Most of the emerging economies are densely populated countries with developing healthcare infrastructures, and the adoption of MRI systems in these regions is expected to increase over the years due to the high burden of diseases such as cancer, musculoskeletal and neurological disorders, and others, coupled with the growth in the aging population.

The growing development of technologically advanced systems and their increasing adoption and product launches increase the availability of these systems in the market and are expected to increase the market segment growth over the forecast period. For instance, in February 2021, Insightec received market approval from the Brazilian HRA, ANVISA, for its Exablate 4000 (Exablate Neuro) platform, which uses MR-guided focused ultrasound to precisely ablate tissue deep within the brain without incisions and will enable treatment for essential tremor and tremor-dominant Parkinson's disease. Similarly, in October 2021, Esaote launched a total body magnetic resonance imaging system called Magnifico Open, which is an open MRI system with cutting-edge technology to satisfy not only clinical needs but also address operational and financial demands.

Furthermore, the rising company's focus on adopting various key strategies, such as expansion, collaborations, and others, is also contributing to the market segment's growth. For instance, in November 2021, a sophisticated MRI facility was launched at the NBRC in Haryana, India. Also, in July 2021, a new magnetic resonance imaging (MRI) scanner facility opened in Leicester for EUR 3.1 billion (USD 3.28 billion), which will increase the current imaging capacity of researchers from 500 cardiovascular research participants a year to 1500. The new scanner facility has been funded by a EUR 1 million (USD 1 million) grant from the BHF.

Therefore, owing to the aforementioned factors, such as the rising number of product launches and increasing company activities, the studied segment is expected to grow over the forecast period.

North America is Expected to Have the Significant Market Share Over the Forecast Period

North America is expected to dominate the market over the forecast period owing to factors such as the rising burden of chronic diseases among the population, the increasing use of advanced technology in healthcare systems, the presence of a well-established healthcare infrastructure, and high healthcare spending. In addition, the growing demand for minimally invasive therapies and rising technological advancements in medical electronics are also expected to increase market growth over the forecast period.

The increasing prevalence and burden of chronic diseases is the key factor driving the demand for medical electronics in the region. For instance, as per the data published by the CDC, in April 2022, an estimated 35 million adults in the United States were expected to suffer from arthritis by 2040. This is expected to increase the demand for medical electronics that provide detailed images of the joint and surrounding tissues that aid in the early detection of the condition, hence boosting the market growth. Also, as per the 2022 statistics published by the ACS, over 1.9 million new cancer cases and 11,030 new cancer cases are expected to be diagnosed in the United States and New Mexico, respectively, in 2022. Also, as per 2022 statistics published by the Canadian Cancer Society, about 233,900 new cancer cases are expected to be diagnosed in Canada in 2022. With the growing burden of cancer cases, the demand for medical electronics such as MRIs, CT scans, and others is increasing, which helps in the early detection of tumors in the body. This is anticipated to fuel market growth over the forecast period.

Furthermore, the rising company activities in developing products and increasing product launches are also contributing to market growth. For instance, in February 2022, the FDA approved Esaote's Magnifico Open MRI, a new open whole-body MRI system in the United States. Also, in July 2021, the USFDA approved Medtronic's two AccuRhythm artificial intelligence (AI) algorithms for use with the LINQ II insertable cardiac monitor (ICM).

Therefore, owing to factors such as the high burden of arthritis and cancer among the population as well as growing company activities in the region, the studied market is anticipated to grow over the forecast period.

Medical Electronics Market Competitor Analysis

The medical electronics market is competitive with the presence of a large number of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions across the world. Some companies currently dominating the market include Medtronics PLC, GE Healthcare, Koninklijke Philips NV, Siemens Healthcare GmbH, and Fujifilm Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Geriatric Population
    • 4.2.2 Rising Application of Imaging Devices
  • 4.3 Market Restraints
    • 4.3.1 Ramped up regulatory scrutiny
    • 4.3.2 High Cost and Maintenance
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Non-invasive Products
      • 5.1.1.1 MRI
      • 5.1.1.2 X-Ray
      • 5.1.1.3 CT Scan
      • 5.1.1.4 Ultrasound
      • 5.1.1.5 Nuclear Imaging Systems
      • 5.1.1.6 Cardiac Monitors
      • 5.1.1.7 Respiratory Monitors
      • 5.1.1.8 Hemodynamic Monitors
      • 5.1.1.9 Multipara Monitors
      • 5.1.1.10 Digital Thermometers
      • 5.1.1.11 Other Products
    • 5.1.2 Invasive Products
      • 5.1.2.1 Endoscopes
      • 5.1.2.2 Pacemakers
      • 5.1.2.3 Implantable Cardioverter Defibrillator (ICD)
      • 5.1.2.4 Implantable Loop Recorders
      • 5.1.2.5 Spinal Cord Stimulator
      • 5.1.2.6 Other Invasive Products
  • 5.2 By Application
    • 5.2.1 Diagnostics
    • 5.2.2 Monitoring
    • 5.2.3 Therapeutics
  • 5.3 By End User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic PLC
    • 6.1.2 GE Healthcare
    • 6.1.3 Koninklijke Philips NV
    • 6.1.4 Siemens Healthcare GmbH
    • 6.1.5 Fujifilm Corporation
    • 6.1.6 McKesson Corporation
    • 6.1.7 Olympus Corporation
    • 6.1.8 Hologic Inc.
    • 6.1.9 Dragerwerk AG & Co. KGaA
    • 6.1.10 Getinge Inc.
    • 6.1.11 Esaote SpA
    • 6.1.12 Canon Medical Systems
    • 6.1.13 Mindray Medical International Limited

7 MARKET OPPORTUNITIES AND FUTURE TRENDS